P3.02b-075 Addition of Bevacizumab for Malignant Pleural Effusion as the Manifestation of Acquired EGFR-TKI Resistance in NSCLC Patients Tao Jiang, Shengxiang Ren, Caicun Zhou Journal of Thoracic Oncology Volume 12, Issue 1, Pages S1235-S1236 (January 2017) DOI: 10.1016/j.jtho.2016.11.1742 Copyright © 2016 Terms and Conditions
Journal of Thoracic Oncology 2017 12, S1235-S1236DOI: (10.1016/j.jtho.2016.11.1742) Copyright © 2016 Terms and Conditions
Journal of Thoracic Oncology 2017 12, S1235-S1236DOI: (10.1016/j.jtho.2016.11.1742) Copyright © 2016 Terms and Conditions